741698-92-0 Usage
Description
Benzoic acid, 4-bromo-3-ethyl(9CI) is an organic compound derived from benzoic acid, featuring a bromine atom at the 4th position and an ethyl group at the 3rd position. It is a white crystalline solid with a distinct chemical structure that makes it a valuable building block in the synthesis of various pharmaceuticals.
Uses
Used in Pharmaceutical Industry:
Benzoic acid, 4-bromo-3-ethyl(9CI) is used as a starting material and a useful building block for the development of various pharmaceuticals. Its unique chemical structure allows for the creation of a wide range of compounds with potential therapeutic applications.
Used in Drug Synthesis:
Benzoic acid, 4-bromo-3-ethyl(9CI) is employed as a key intermediate in the synthesis of various drugs. Its presence in the molecular structure can contribute to the drug's efficacy, stability, and pharmacological properties, making it an essential component in the development of new medications.
Check Digit Verification of cas no
The CAS Registry Mumber 741698-92-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,4,1,6,9 and 8 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 741698-92:
(8*7)+(7*4)+(6*1)+(5*6)+(4*9)+(3*8)+(2*9)+(1*2)=200
200 % 10 = 0
So 741698-92-0 is a valid CAS Registry Number.
741698-92-0Relevant articles and documents
TBK/IKK INHIBITOR COMPOUNDS AND USES THEREOF
-
, (2017/01/23)
The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as TBK/IKKε inhibitors.
AMINO ALCOHOL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND USE THEREOF
-
Page/Page column 26-27, (2008/06/13)
The present invention provides compounds represented by general formula (I): or pharmaceutical acceptable salts thereof, wherein R1 and R2 are each hydrogen or lower alkyl; R3 R4, R5 and R6 are each hydrogen, halogen, lower alkyl or lower alkoxy; R7 and R8 are each hydrogen, halogen, lower alkyl, halo-lower alkyl, lower alkoxy, cycloalkyl, aryl, heteroaryl, cyano, a hydroxyl group, lower acyl, carboxy or the like; R9 is -C(O)-R10, -A1-C(O)-R10, -O-A2-C(O)-R10 or a tetrazol-5-yl group, which exhibit potent and selective β3-adrenoceptor stimulating activities. The present invention also provides pharmaceutical compositions containing said compound, and uses thereof.
